Two supplements appear regularly in longevity conversations: fisetin, a flavonoid found in strawberries, and nicotinamide mononucleotide (NMN), a precursor to the essential coenzyme NAD+. They are often lumped together as ‘anti-aging’ supplements, but they target distinct biological problems. Fisetin is studied as a senolytic — a compound that may selectively clear aged, dysfunctional cells sometimes called ‘zombie cells.’ NMN is studied as a way to replenish NAD+, a molecule whose decline with age is tied to falling cellular energy and impaired DNA repair.
Understanding what each compound actually does — and what the evidence currently supports — matters before adding either to a routine. This article walks through the proposed mechanisms, the state of human research, and the honest limitations of both, so you can have an informed conversation with a healthcare provider.
Key Takeaways
- Fisetin and NMN address different mechanisms of aging: fisetin targets senescent ‘zombie’ cells; NMN aims to restore declining NAD+ levels and cellular energy.
- NMN has more published human clinical data, including trials confirming it raises blood NAD+ safely in healthy adults [2] and with continued use over months [4].
- Fisetin’s human evidence is preliminary and focused on safety; the high intermittent doses used in senolytic protocols have not been established as safe or effective in large trials.
- Neither compound has proven human lifespan extension; the mechanistic rationale for both is scientifically grounded but still under investigation [6] [3].
- Combining the two is conceptually logical (different targets) but lacks robust human trial data; consult a physician before starting either, especially if taking medications.
What Are Senescent Cells and Why Fisetin Targets Them
Cellular senescence is a state in which a cell stops dividing but resists normal programmed cell death (apoptosis). These cells accumulate in tissues with age and secrete a mix of inflammatory proteins — collectively called the senescence-associated secretory phenotype, or SASP — that can damage neighboring healthy cells. In animal models, the buildup of senescent cells has been associated with tissue dysfunction and accelerated aging phenotypes.
Fisetin is a naturally occurring flavonoid concentrated in strawberries and found in smaller amounts in apples, onions, and cucumbers. Preclinical research has suggested it acts as a senolytic by reactivating apoptotic pathways in senescent cells while leaving healthy cells largely unaffected. Notably, studies in aged mice showed meaningful reductions in senescent cell burden and improvements in measures of health span when fisetin was administered intermittently. Early human trials have examined it in contexts such as frailty and COVID-19 recovery, though these are small and results remain preliminary. No fisetin preparation is FDA-approved to treat, cure, or prevent any disease.
What Is NAD+ and Why NMN Is Studied as a Precursor
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It is essential for converting nutrients into cellular energy via the mitochondrial electron transport chain, for activating sirtuins (proteins linked to stress resistance and longevity), and for powering DNA-repair enzymes called PARPs. NAD+ levels decline substantially with age — by roughly half between young adulthood and midlife — and this decline has been proposed as a contributor to the metabolic and functional changes associated with aging [3].
NMN is a direct biosynthetic precursor to NAD+. Taken orally, it enters cells and is converted to NAD+ through a single enzymatic step. A systematic review of both preclinical and clinical evidence on NAD+ supplementation found broad support for the concept that boosting NAD+ through precursors like NMN can restore cellular signaling pathways that deteriorate with age, though the authors noted that large, long-term randomized controlled trials in humans remain limited [6]. NMN is sold as a dietary supplement and is not approved by the FDA for any therapeutic indication.
Human Evidence for NMN: What Clinical Studies Show
The human evidence for NMN is more developed than for fisetin, though still in early stages. A randomized, placebo-controlled trial found that oral NMN supplementation significantly increased blood NAD+ concentrations in healthy adults within weeks of beginning supplementation, and the compound was well tolerated at doses up to 900 mg per day [2]. This is an important proof-of-concept finding: the precursor successfully reaches circulation and drives NAD+ synthesis.
A longer-term study of healthy, middle-aged Japanese men taking NMN for up to 12 weeks found continued increases in blood NAD+ levels alongside improvements in sleep quality metrics, with no serious adverse events reported [4]. A benefit/risk analysis framed NMN and related NAD+ precursors as having a favorable safety profile in aging-related research contexts, while noting that definitive proof of benefit in humans awaits larger trials [1].
One area with emerging human data is skeletal muscle. A 2025 systematic review and meta-analysis examined whether NMN and a related NAD+ precursor (NMR) affected skeletal muscle mass and function. It found some signals toward benefit in measures of muscle performance, though the authors concluded the evidence was not yet sufficient to make firm clinical recommendations, given heterogeneity across studies [5]. This is relevant because age-related muscle loss (sarcopenia) is one of the most functionally significant aspects of aging.
Fisetin vs NMN: Different Problems, Different Mechanisms
The most important distinction between fisetin and NMN is that they address different root causes of cellular aging — and those causes are not mutually exclusive. NMN works upstream, trying to restore the energy currency and signaling capacity of cells so they can continue functioning well. Fisetin works as a form of cellular housekeeping, attempting to remove cells that have already broken down irreversibly and are actively harming their neighbors through chronic inflammation.
An analogy: if aging tissue were a factory, NMN would be about restoring the fuel supply so the machinery runs better. Fisetin would be about removing broken machines that are jamming the assembly line and leaking toxins. Both could be relevant to the same aging tissue, but neither directly compensates for what the other does. This is why researchers studying longevity interventions have begun looking at combination senolytic and NAD+ restoration strategies in preclinical models, though robust human data on such combinations does not yet exist.
From an evidence standpoint, NMN currently has more published human trial data, including biomarker readouts (blood NAD+ levels) that confirm biological activity. Fisetin’s human data is thinner, focused on safety and feasibility in older adults, with efficacy outcomes still preliminary. Neither has proven human longevity extension in controlled trials.
Dosing Approaches and Practical Considerations
NMN is typically taken daily in doses ranging from 250 mg to 1,000 mg. The clinical trial confirming blood NAD+ elevation used doses up to 900 mg and found dose-dependent increases, suggesting higher doses drive more NAD+ synthesis within the range studied [2]. Long-term studies using doses in this range have found no serious safety signals in healthy adults [4], though data beyond 12 months in humans is limited [6].
Fisetin protocols studied in senolytic research differ substantially from the daily-dosing model used for NMN. Because senolytics are proposed to work by periodically clearing accumulated senescent cells rather than providing continuous metabolic support, preclinical and early human protocols have used high intermittent doses — for example, two to three consecutive days of relatively high intake, repeated monthly or quarterly. These intermittent high-dose schedules have not been established as safe or effective in large human trials. Individuals taking blood thinners, immunosuppressants, or CYP3A4-sensitive medications should consult a physician before using fisetin at any dose, as flavonoids can interact with drug-metabolizing enzymes.
Where the Evidence Falls Short and What to Watch For
For NMN, the gap between what has been measured (elevated blood NAD+ levels) and what has been demonstrated (improved health outcomes that matter to patients, like reduced disease risk or extended lifespan) remains real. A comprehensive 2023 review of NAD+ precursors in human health concluded that while the mechanistic rationale is strong and short-term safety data are encouraging, the field still needs large, adequately powered randomized controlled trials with clinical endpoints to confirm the benefits widely discussed in longevity circles [3].
For fisetin, the human trial base is smaller, and most studies have been designed as safety and feasibility trials rather than efficacy trials. Extrapolating from mouse lifespan extension data to human outcomes involves assumptions that have not always held in other areas of aging research. The senolytic hypothesis is scientifically plausible and actively studied, but it remains a hypothesis in humans.
Neither supplement should be viewed as a substitute for the lifestyle factors — regular physical activity, adequate sleep, dietary quality, not smoking — that have the strongest evidence for healthy aging across populations. Both are areas of legitimate scientific interest and neither should be dismissed or over-hyped.
🛒 Where to Buy Fisetin
- Life Extension Bio-FisetinLab-tested / studied
capsules, 24 mg per capsule (enhanced-bioavailability liposomal blend) — One of the category’s flagship products; liposomal delivery is designed to improve oral absorption; the lower per-capsule dose requires stacking multiple capsules for research-level senolytic protocols - NOW Foods Fisetin
capsules, 100 mg per capsule — NSF-certified GMP facility; widely available at retail and online; reliable entry-level option for low-dose daily regimens - Double Wood Supplements Fisetin
capsules, 100 mg per capsule (60 count) — USA-manufactured and third-party tested; consistently strong Amazon ratings; popular choice in r/longevity for cost-effective daily use - Swanson Fisetin
capsules, 100 mg per capsule — Established supplement brand with broad distribution; budget-friendly for users wanting a recognizable name at a low cost per dose
As an Amazon Associate we earn from qualifying purchases. Shilajit quality varies widely — always choose a product with a published third-party heavy-metal test (COA) before buying.
A Note on the Evidence
Neither fisetin nor NMN is approved by the FDA to treat, cure, or prevent any disease, and neither has been proven to extend human lifespan in controlled trials; the evidence supporting both compounds, while scientifically interesting, is still early and largely limited to biomarker changes and small trials. Individuals taking blood thinners, CYP3A4-sensitive medications, or any prescription drugs should consult a qualified healthcare provider before using either supplement, and nothing in this article constitutes medical advice.
Frequently Asked Questions
Can fisetin and NMN be taken together?
There is no published human trial specifically studying the combination. Theoretically they target different pathways — senescent cell clearance versus NAD+ restoration — so they are not redundant. However, the absence of combination safety data means discussing both with a physician before combining them is prudent, particularly if you take any prescription medications.
Does NMN actually raise NAD+ levels in humans?
Yes, this has been demonstrated in clinical trials. A randomized controlled trial found that oral NMN significantly increased blood NAD+ levels in healthy adults, with a dose-dependent response and good tolerability up to 900 mg per day [2]. A separate study in middle-aged men found the effect persisted with continued supplementation over months [4].
Is fisetin just a strawberry extract?
Fisetin is a flavonoid naturally concentrated in strawberries, but the amounts in typical food servings are far below the doses used in senolytic research protocols. Supplement forms provide standardized doses. The senolytic protocols studied in preclinical and early human research use intermittent high-dose approaches that cannot be replicated through diet alone.
Who should avoid NMN or fisetin?
Anyone on prescription medications — particularly blood thinners, immunosuppressants, or drugs metabolized by CYP3A4 enzymes — should consult a physician before using either supplement. Pregnant or breastfeeding individuals are generally advised to avoid supplements not specifically studied in those populations. A benefit/risk review of NAD+ supplementation highlighted the need for physician guidance in individuals with existing metabolic or hepatic conditions [1].
Does NMN help with muscle loss as we age?
Early data is cautiously promising but not conclusive. A 2025 systematic review and meta-analysis found some signals that NMN and related NAD+ precursors may support skeletal muscle mass and function, but concluded the evidence is insufficient for firm clinical recommendations and called for larger, longer trials [5].
Is fisetin FDA-approved for any condition?
No. Fisetin is sold as a dietary supplement in many countries and is not FDA-approved to treat, cure, or prevent any disease. The same applies to NMN. Both are subjects of active research and are available over the counter, but regulatory approval requires evidence from large, controlled clinical trials demonstrating safety and efficacy for a specific indication — that evidence does not yet exist for either compound.
References
- Braidy N et al. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Experimental gerontology (2020). PMID 31917996
- Okabe K et al. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. Frontiers in nutrition (2022). PMID 35479740
- Yaku K et al. NAD(+) Precursors in Human Health and Disease: Current Status and Future Prospects. Antioxidants & redox signaling (2023). PMID 37335049
- Yamaguchi S et al. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men. Endocrine journal (2024). PMID 38191197
- Prokopidis K et al. The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of cachexia, sarcopenia and muscle (2025). PMID 40275690
- Gallagher C et al. NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing research reviews (2026). PMID 41655607
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
